Correlation Between Medipharm Labs and Canntab Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medipharm Labs and Canntab Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medipharm Labs and Canntab Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medipharm Labs Corp and Canntab Therapeutics Limited, you can compare the effects of market volatilities on Medipharm Labs and Canntab Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medipharm Labs with a short position of Canntab Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medipharm Labs and Canntab Therapeutics.

Diversification Opportunities for Medipharm Labs and Canntab Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Medipharm and Canntab is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Medipharm Labs Corp and Canntab Therapeutics Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Canntab Therapeutics and Medipharm Labs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medipharm Labs Corp are associated (or correlated) with Canntab Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Canntab Therapeutics has no effect on the direction of Medipharm Labs i.e., Medipharm Labs and Canntab Therapeutics go up and down completely randomly.

Pair Corralation between Medipharm Labs and Canntab Therapeutics

Assuming the 90 days horizon Medipharm Labs is expected to generate 38.88 times less return on investment than Canntab Therapeutics. But when comparing it to its historical volatility, Medipharm Labs Corp is 6.24 times less risky than Canntab Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Canntab Therapeutics Limited is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  1.76  in Canntab Therapeutics Limited on November 2, 2024 and sell it today you would lose (1.75) from holding Canntab Therapeutics Limited or give up 99.43% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.8%
ValuesDaily Returns

Medipharm Labs Corp  vs.  Canntab Therapeutics Limited

 Performance 
       Timeline  
Medipharm Labs Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medipharm Labs Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's forward indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.
Canntab Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Canntab Therapeutics Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental drivers, Canntab Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Medipharm Labs and Canntab Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medipharm Labs and Canntab Therapeutics

The main advantage of trading using opposite Medipharm Labs and Canntab Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medipharm Labs position performs unexpectedly, Canntab Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Canntab Therapeutics will offset losses from the drop in Canntab Therapeutics' long position.
The idea behind Medipharm Labs Corp and Canntab Therapeutics Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators